Papers

4

Total Citations

34

H-Index

2

About

Dr. A. Cestari is a pioneering urologic surgeon whose research has significantly advanced the surgical management of urologic cancers and complex hernias. His work is centered on refining minimally invasive and robotic-assisted techniques to improve oncologic outcomes and preserve patient quality of life. A landmark contribution is his demonstration that complete metastasectomy is an independent predictor of cancer-specific survival in patients with clinically metastatic renal cell carcinoma (2010, 15 citations), a finding that has influenced surgical decision-making for advanced disease. Dr. Cestari has also been at the forefront of robotic surgery innovation, describing the first totally extraperitoneal (TEP) bilateral hernioplasty using the Single Site da Vinci platform (2016, 15 citations), a novel technique that reduces operative trauma. His comparative studies on erectile function recovery after nerve-sparing radical prostatectomy, contrasting open and robotic approaches (2010), and his multicenter analysis of predictors of warm ischemia time during robot-assisted partial nephrectomy (2012) provide critical data for optimizing surgical outcomes. With over 30 citations across his most influential works, Dr. Cestari’s research continues to shape the evolution of robotic urologic surgery, offering patients safer, more effective, and function-preserving treatments.

Research Focus

Key Achievements

2
H-Index
4
Papers
34
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
450 COMPLETE METASTASECTOMY IS AN INDEPENDENT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH CLINICALLY METASTATIC RENAL CELL CARCINOMA
15 citations · 2010
📈 Most Prolific Year: 2010 (2 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: Istituti di Ricovero e Cura a Carattere Scientifico

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago